Quick Links
About MyDepressionTeam
Powered By
Overview
Spravato is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with treatment-resistant depression (TRD), either alone or in combination with an oral…
Overview
Brixadi is approved by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe opioid use disorder in individuals who have started treatment with a transmucosal buprenorphine product…
Overview
Saphris is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia in adults and for the treatment of bipolar 1 disorder in both adults and children aged 10 to 17. For bipolar 1…
Overview
Vraylar is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia in adults. It is also approved for the acute treatment of manic or mixed episodes and depressive episodes…
Overview
Caplyta is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia in adults and for depressive episodes associated with bipolar 1 or bipolar 2 disorder (bipolar depression) in…
Overview
Vivitrol is approved by the U.S. Food and Drug Administration (FDA) for the prevention of relapse to opioid dependence in people who have completed opioid detoxification. It is intended for individuals who are…
Overview
Rykindo is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia in adults and for the maintenance treatment of bipolar 1 disorder, either as monotherapy or as an adjunct to…
Overview
Invega is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia in adults and adolescents ages 12 to 17. It may be prescribed as a first-line treatment for individuals newly…
Overview
Methadone is approved by the U.S. Food and Drug Administration (FDA) for the treatment of opioid use disorder (OUD) in adults. It is used to reduce withdrawal symptoms and cravings in people who are dependent on…
Overview
Geodon is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia in adults, and for the treatment of manic or mixed episodes associated with bipolar 1 disorder. For bipolar 1…
Join